Paperless Batch Records for the Masses

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-11-15-2016
Volume 2016 eBook
Issue 3
Pages: s14–s20

In InstantGMP, cloud-based IT and an approach grounded in cGMPs, brings more of the power of paperless recordkeeping to manufacturers, at a fraction of the cost.

In InstantGMP, cloud-based IT and an approach grounded in cGMPs, brings more of the power of paperless recordkeeping to manufacturers, at a fraction of the cost.

CEO Rick Soltero, who worked In quality, manufacturing and R&D before establishing the company, talks about the challenges facing small-to-mid-sized pharma companies in modernizing their recordkeeping systems, and how important it is that solutions be grounded in cGMPs. 

Download Pharmaceutical Technology’s 

2016 Quality Throughout the Supply Chain eBook

.

Articles in this issue
PTeBook1116_QMS_185.jpg
Extending QMS to Contract Partners
PTeBook1116_Agalloco_sterilization_185.jpg
Too Much by Half: Misapplication of the Half-Cycle Approach to Sterilization
PTeBook1116_HumanPerformance_BPOG_185.jpg
Investigation Effectiveness Drives Human Performance Excellence
PTeBook1116_Aging_Facilities_185.jpg
Is Global Regulatory Gridlock Slowing Modernization?
PTeBook1116_Instant_GMP_185.jpg
Paperless Batch Records for the Masses
PTeBook1116_Pharma_Report_Card_185.jpg
Could Greater Transparency Improve Pharmaceutical Quality and Compliance?
PTeBook1116_Capsugel_185.jpg
Ensuring Quality in Pharmaceutical Raw Materials
PTeBook1116_MicrobialTesting_Challener_185.jpg
Microbiological Testing: Time is of the Essence
Recent Videos
US tariff rate rising , trade policy , business graph and dollars banknote , tax calculation change | Image Credit: © janews094 - stock.adobe.com
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

FDA Grants Fast Track Designation to Q32 Bio Treatment for Alopecia Areata

Patrick Lavery
April 30th 2025
Article

Bempikibart (ADX-914) is a human anti-IL-7Rα antibody that blocks the IL-7 and TSLP pathways, which have been implicated in driving T cell-mediated pathological processes in autoimmune diseases.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

CARBOGEN AMCIS Shanghai Site Gets Drug Manufacturing License from China’s NMPA

Patrick Lavery
April 24th 2025
Article
Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Drug Solutions Podcast: All About Data: Looking at the EHDS in More Detail

Felicity Thomas
May 28th 2024
Podcast

In this episode, Alexander Natz from EUCOPE chats about the European Health Data Space.

Hand shaking which print screen on wooden cube block in front of human icon for business deal and agreement concept. | Image Credit: © Dilok - stock.adobe.com

Paige, Sonrai Form Partnership to Harness AI for Precision Medicine R&D

Patrick Lavery
April 21st 2025
Article
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

FDA Announces New Policy on Advisory Committee Members

Patrick Lavery
April 18th 2025
Article

The policy announced by Commissioner Martin A. Makary, MD, will not preclude employees of regulated companies from presenting their views to committees, and rare exceptions will be allowed.